QR код

Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors

Introduction Few studies have reported the outcomes of adolescents and young adults (AYAs) with chronic-phase chronic myeloid leukaemia (CML-CP) on tyrosine kinase inhibitors (TKIs).Materials and methods We retrospectively analysed the clinical features, treatment response, and long-term outcomes of...

Повний опис

Збережено в:
Автори: Yuriko Nishiyama-Fujita, Tomonori Nakazato, Noriyoshi Iriyama, Michihide Tokuhira, Maho Ishikawa, Eriko Sato, Tomoiku Takaku, Keiji Sugimoto, Hiroyuki Fujita, Isao Fujioka, Shun Tsuchiya, Yuta Kimura, Eisaku Iwanaga, Norio Komatsu, Norio Asou, Masahiro Kizaki, Yoshihiro Hatta, Tatsuya Kawaguchi
Формат: Artigo
Мова:Inglês
Опубліковано: Taylor & Francis Group 2022-12-01
Серія:Annals of Medicine
Предмети:
Chronic phase chronic myeloid leukaemia
adolescents and young adults
tyrosine kinase inhibitors
Dasatinib
Nilotinib
Онлайн доступ:https://www.tandfonline.com/doi/10.1080/07853890.2022.2069280
Теги: Додати тег
Немає тегів, Будьте першим, хто поставить тег для цього запису!

Схожі ресурси